43 results
Thumbnail

D1.233 - Pembrolizumab IgE mediated drug hypersensitivity reaction and successful desensitisation

Thumbnail

D1.234 - The Importance of Differential Diagnosis in DRESS Syndrome: Review of 2 Cases

Thumbnail

D1.235 - Clorhexidine allergy in northern area of Seville

Thumbnail

D1.236 - Clinical Outcomes of Neuromuscular Blocking Agent Rechallenge Based on Skin Prick Test in Patients with Intraoperative Anaphylaxis

Thumbnail

D1.237 - What Do Drug Skin Tests Tell Us About Quinolone Allergy? Adult Allergy Reference Center Experience

Thumbnail

D1.238 - Urgent desensitization to amiodarone

Thumbnail

D1.239 - Nonsteroidal anti-inflammatory drug cross-hypersensitivity phenotypes show high carbonyl levels

Thumbnail

D1.243 - L-asparaginase desensitization in children

Thumbnail

D1.244 - Retrospective Analysis of Adverse Reactions to Iodinated Contrast Media: Experience in 165 Patients

Thumbnail

D1.245 - Platinum salt hypersensitivity: Experience of our Center

Thumbnail

D1.246 - Cephalosporin Allergy in Children

Thumbnail

D1.247 - Tolerance to intravenous sodium heparin despite a positive subcutaneous challenge test: A case report

Thumbnail

D2.167 - Effect of Metformin on allergen specific immunotherapy

Thumbnail

D2.169 - Association of Antenatal Corticosteroid Treatment with Risk of Allergic Diseases in Children

Thumbnail

D2.174 - Patient survey to determine the minimal clinically important difference for a combined symptom and medication score in grass AIT

Thumbnail

D2.179 - Evaluation of Sublingual Immunotherapy for Cat Allergy: Results from a Non-Interventional Study

Thumbnail

D2.168 - Systemic reactions to subcutaneous immunotherapy in children

Thumbnail

D2.170 - The placebo effect leads to significantly lower values regarding allergic symptoms and medication use in birch-pollen allergic patients during the birch pollen season

Thumbnail

D2.171 - The individual benefit of subcutaneous immunotherapy with mannan-conjugated birch pollen allergoids is already evident in the first season immediately after treatment

Thumbnail

D2.172 - Subcutaneous immunotherapy with a depigmented cat allergoid in patients with cat allergy is safe and results primarily in delayed local reactions